Could This Low Float Nasdaq Profile Be A Major Breakout Target Based On 3 Game-Changing Potential Catalysts?
Full Report Arrives 9:30AM EST Tomorrow
Sign Up To My SMS Update System - Directions Below
With all the turmoil surrounding the pandemic, it's sad to think about all the illness that still transpired outside of actually catching CV19.
Long story short, cancer hasn't gone anywhere.
In fact the global cancer therapeutics market size was valued at $98Bn in 2018 and is estimated to reach $180.1Bn by 2026 according to Allied Market Research.
With so much growth potential within the market, it's important to look at under-the-radar companies who may not yet have the biggest fanbase on Wall Street quite yet.
I've uncovered one such company who could be on the verge of making a name for themselves in the near future.
At 9:30AM EST tomorrow, you receive the full Nasdaq company name and symbol along with a full report.
To give you a taste of what's coming, I've put together a short list of potential catalysts that could fuel near term vertical growth for this profile.
Top 3 Potential Catalysts - Key Details On Your New Nasdaq Profile For Thursday AM
#1. Guess what? This is another low float profile. Yahoo Finance is reporting this profile to have fewer than 10Mn shares in its float which means volatility could be an every day occurrence.
#2. As of close on Tuesday, this profile was displaying several oversold leaning technical indicators including 9-Day and 14-Day Relative Strength Indices below 35%.
Could a healthy reversal be fast approaching?
#3. A recent Nasdaq listing could draw serious attention to this company and provide a new visibility from the retail and institutional side of things like they've never seen before.
Since you've got a moment now, do this: